Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE and Uses Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 10 of these applications claim priority to application 16/537,394, filed Aug 9, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,590,087 | Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE and Uses Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | ||
| US 10,710,966 | Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE and Uses Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | ||
| US 10,941,118 | Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE and Uses Thereof In force · Low confidence | Pfizer Inc. | In force | Low confidence | ||
| US 11,820,748 | Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE and Uses Thereof In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | ||
| US 11,845,732 | Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE and Uses Thereof In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | ||
| US 11,884,634 | Compositions of Solid Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | ||
| US 11,884,635 | Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE and Uses Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | ||
| US 11,905,255 | Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE and Uses Thereof In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | ||
| US 12,116,347 | Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE and Uses Thereof In force · Low confidence | Pfizer Inc. | In force | Low confidence | ||
| US 12,297,177 | Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE and Uses Thereof In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | ||
| 2 more patents in this group · Pro | ||||||
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
11 of these are in force and held by Pfizer Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.